Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fogelman

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Pediatric Emergency Care|April 1, 1995
Assessment of the terminal 40-millisecond QRS vector in children with a history of tricyclic antidepressant ingestionM Berkovitch, D Matsui, R Fogelman, et al.
Cardiology in the Young|July 1, 1999
Acute complications in the current era of therapeutic cardiac catheterization for congenital heart diseaseB Zeevi, M Berant, R Fogelman, et al.
The Canadian Journal of Cardiology|July 1, 1996
Torsade de pointes, acquired complete heart block and inappropriately long QT in childhoodG Gladman, A M Davis, R Fogelman, et al.
Circulation|August 15, 1995
Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-upR Fogelman, D Nykanen, J F Smallhorn, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Current Treatment Options in Gastroenterology|September 4, 2004
Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic CancerHarold Frucht, Peter D. Stevens, David R. Fogelman, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2007
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysisRobert L Fine, David R Fogelman, Stephen M Schreibman, et al.
Journal of Pain and Symptom Management|January 27, 2020
A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic CancerMona Kamal, Xin Shelley Wang, Qiuling Shi, et al.
Oncology|February 17, 2016
Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal CancerXin Shelley Wang, Qiuling Shi, Patrick M Dougherty, et al.
Surgical Oncology Clinics of North America|September 8, 2004
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTXDavid R Fogelman, Johnson Chen, John A Chabot, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Pediatric Emergency Care|April 1, 1995
Assessment of the terminal 40-millisecond QRS vector in children with a history of tricyclic antidepressant ingestionM Berkovitch, D Matsui, R Fogelman, et al.
Cardiology in the Young|July 1, 1999
Acute complications in the current era of therapeutic cardiac catheterization for congenital heart diseaseB Zeevi, M Berant, R Fogelman, et al.
The Canadian Journal of Cardiology|July 1, 1996
Torsade de pointes, acquired complete heart block and inappropriately long QT in childhoodG Gladman, A M Davis, R Fogelman, et al.
Circulation|August 15, 1995
Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-upR Fogelman, D Nykanen, J F Smallhorn, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Current Treatment Options in Gastroenterology|September 4, 2004
Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic CancerHarold Frucht, Peter D. Stevens, David R. Fogelman, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2007
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysisRobert L Fine, David R Fogelman, Stephen M Schreibman, et al.
Journal of Pain and Symptom Management|January 27, 2020
A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic CancerMona Kamal, Xin Shelley Wang, Qiuling Shi, et al.
Oncology|February 17, 2016
Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal CancerXin Shelley Wang, Qiuling Shi, Patrick M Dougherty, et al.
Surgical Oncology Clinics of North America|September 8, 2004
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTXDavid R Fogelman, Johnson Chen, John A Chabot, et al.
Pageof 6